Insider Trading disclosures for Axogen Inc.

The latest disclosure was made by Michael J. Dale in Axogen Inc. where a trade of 176,300 Restricted Stock Units done was reported to US exchanges on March 25, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Michael J. Dale	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2025	176,300	176,300	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2025	38,000	38,000	-		-	Restricted Stock Units
Jens Kemp	Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2025	38,000	38,000	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	2,950	0	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	6,362	6,363	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	23,150	23,150	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	2,950	203,361 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	6,362	209,723 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2025	23,150	232,873 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Sale of securities on an exchange or to another person at price $ 17.50 per share.	16 Mar 2025	15,111	217,762 (0%)	0%	17.5	264,443	Common Stock
Jens Kemp	Chief Marketing Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.36 per share.	04 Mar 2025	4,003	27,683 (0%)	0%	18.4	73,495	Common Stock
Amy A. Wendell	Director	Sale of securities on an exchange or to another person at price $ 20.02 per share.	03 Mar 2025	5,000	97,899 (0%)	0%	20.0	100,100	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2025	24,799	209,301 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.35 per share.	28 Feb 2025	8,296	201,005 (0%)	0%	18.4	152,232	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2025	2,500	185,474 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.50 per share.	22 Feb 2025	972	184,502 (0%)	0%	16.5	16,038	Common Stock
Jens Kemp	Chief Marketing Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2025	2,500	2,500 (0%)	0%		0	Common Stock
Jens Kemp	Chief Marketing Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.49 per share.	22 Feb 2025	814	1,686 (0%)	0%	16.5	13,423	Common Stock
Jens Kemp	Chief Marketing Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.49 per share.	22 Feb 2025	814	31,686 (0%)	0%	16.5	13,423	Common Stock
Jens Kemp	Chief Marketing Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2025	2,500	32,500 (0%)	0%		0	Common Stock
Nir Naor	CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share.	06 Jan 2025	39,132	260,868 (0%)	0%	15.2	595,589	Common Stock
Joseph Adrian Tyndall	Director	Purchase of securities on an exchange or from another person at price $ 10.50 per share.	31 Dec 2024	2,525	25,082 (0%)	0%	10.5	26,513	Common Stock
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2024	2,875	34,927 (0%)	0%		-	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Sep 2024	2,500	179,974 (0%)	0%		0	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	90,816 (0%)	0%		0	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
John H. Johnson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	29,016 (0%)	0%		0	Common Stock
John H. Johnson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
Paul G. Thomas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	32,052 (0%)	0%		0	Common Stock
Paul G. Thomas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	102,899 (0%)	0%		0	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
William P. Burke	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	28,557 (0%)	0%		0	Common Stock
William P. Burke	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	40,816 (0%)	0%		0	Common Stock
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
Joseph Adrian Tyndall	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	0	-		-	Restricted Stock Units
Joseph Adrian Tyndall	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2024	11,904	22,557 (0%)	0%		0	Common Stock
Michael D. Dale	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Aug 2024	450,000	450,000	-		-	Performance Stock Units
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	78,912 (0%)	0%		-	Common Stock
John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	17,112 (0%)	0%		-	Common Stock
John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	20,148 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	90,995 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Stock Option (right to purchase)
William P. Burke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	16,653 (0%)	0%		-	Common Stock
William P. Burke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	28,912 (0%)	0%		-	Common Stock
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Joseph Adrian Tyndall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Joseph Adrian Tyndall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	10,653 (0%)	0%		-	Common Stock
Kathy Johnson Weiler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	18,248	18,248	-		-	Employee Stock Option (right to purchase)
Kathy Johnson Weiler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	10,653	10,653 (0%)	0%		-	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jun 2024	11,904	0	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jun 2024	11,904	283,498 (0%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	33,028	1,124,565 (2%)	0%	7.7	253,655	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,500	1,137,065 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	3,086	1,133,979 (2%)	0%	7.7	23,700	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,975	1,146,954 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	3,166	1,143,788 (2%)	0%	7.7	24,315	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	84,847	84,847	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,500	12,500	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,975	0	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	84,847	1,157,593 (2%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	3,000	166,377 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,725	12,725	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,950	2,950	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	3,000	0	-		-	Restricted Stock Units
Erick Wayne DeVinney	Chief Innovation Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	3,141	177,474 (0%)	0%	7.7	24,123	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	12,725	180,615 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	721	167,890 (0%)	0%	7.7	5,537	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,950	168,611 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	716	165,661 (0%)	0%	7.7	5,499	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	18,625	18,625	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	3,000	38,708 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	716	37,992 (0%)	0%	7.7	5,499	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,950	40,942 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	721	40,221 (0%)	0%	7.7	5,537	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	18,625	58,846 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	4,596	54,250 (0%)	0%	7.7	35,297	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	3,000	0	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,950	2,950	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	5,251	52,999 (0%)	0%	7.7	40,328	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	4,125	57,124 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	1,020	56,104 (0%)	0%	7.7	7,834	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,500	58,604 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Sale of securities on an exchange or to another person at price $ 7.68 per share.	16 Mar 2024	610	57,994 (0%)	0%	7.7	4,685	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	21,281	21,282	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	4,125	4,125	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	2,500	0	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2024	21,281	58,250 (0%)	0%		0	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 9.00 per share.	07 Mar 2024	25,000	271,594 (0%)	0%	9	225,000	Common Stock
Michael Patrick Donovan	VP Operations	Sale of securities on an exchange or to another person at price $ 8.81 per share.	07 Mar 2024	36,310	35,708 (0%)	0%	8.8	319,891	Common Stock
Erick Wayne DeVinney	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	50,000	163,377 (0%)	0%		-	Common Stock
Kemp Jens	Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2024	68,600	68,600	-		-	Performance Stock Units
DeVinney Erick Wayne	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2024	68,600	68,600	-		-	Performance Stock Units
Naor Nir	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	300,000	300,000 (0%)	0%		-	Common Stock
Weiler Kathy Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Dec 2023	65,476	65,476	-		-	Stock Option (right to purchase)
Mariani J. Peter	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 7.52 per share.	11 Dec 2023	1,410	74,693 (0%)	0%	7.5	10,603	Common Stock
J. Mariani Peter	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 7.51 per share.	11 Dec 2023	3,120	71,573 (0%)	0%	7.5	23,431	Common Stock
J. Peter Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 7.50 per share.	11 Dec 2023	7,970	63,603 (0%)	0%	7.5	59,775	Common Stock
William P. Burke	Director	Purchase of securities on an exchange or from another person at price $ 6.56 per share.	23 Aug 2023	10,000	10,000 (0%)	0%	6.6	65,600	Common Stock
William P. Burke	Director	Grant, award, or other acquisition of securities at price $ 6.31 per share.	23 Aug 2023	6,000	6,000 (0%)	0%	6.3	37,860	Common Stock
Guido J. Neels	Director	Purchase of securities on an exchange or from another person at price $ 6.11 per share.	16 Aug 2023	10,000	68,259 (0%)	0%	6.1	61,100	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	58,259 (0%)	0%		0	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
John H. Johnson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
John H. Johnson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	6,459 (0%)	0%		0	Common Stock
Paul G. Thomas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	9,495 (0%)	0%		0	Common Stock
Paul G. Thomas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	70,342 (0%)	0%		0	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	296,594 (0%)	0%		0	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 8.74 per share.	01 Jun 2023	29,480	290,135 (0%)	0%	8.7	257,655	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 8.65 per share.	01 Jun 2023	12,500	319,615 (0%)	0%	8.7	108,125	Common Stock
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	0	-		-	Restricted Stock Units
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2023	6,459	18,259 (0%)	0%		0	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 9.17 per share.	23 May 2023	2,828	336,755 (0%)	0%	9.2	25,933	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 9.26 per share.	23 May 2023	4,640	332,115 (0%)	0%	9.3	42,966	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.22 per share.	12 May 2023	25,000	60,133 (0%)	0%	9.2	230,500	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.22 per share.	12 May 2023	3,750	63,883 (0%)	0%	9.2	34,575	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 May 2023	3,750	0	-		-	Stock Option (right to buy)
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 May 2023	25,000	0	-		-	Stock Option (right to buy)
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	15,250	15,250	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	94,500	94,500	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	65,600	65,600	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,866	65,579 (0%)	0%	8.3	15,432	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	15,250	80,829 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	5,172	75,657 (0%)	0%	8.3	42,772	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,500	5,500	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,500	67,445 (0%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	12,975	1,050,670 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	112,000	112,000	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	179,000	179,000	-		-	Employee Stock Option (right to purchase)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	12,975	12,975	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	25,000	1,037,695 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	25,000	25,000	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	113,596 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,835	110,596 (0%)	0%	8.3	15,175	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	112,431 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	46,300	46,300	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	64,000	64,000	-		-	Employee Stock Option (right to purchase)
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	3,000	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	5,900	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	934	112,662 (0%)	0%	8.3	7,724	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	30,898 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	22,061 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	933	21,128 (0%)	0%	8.3	7,716	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	1,250	22,378 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	389	21,989 (0%)	0%	8.3	3,217	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	4,367	26,356 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,358	24,998 (0%)	0%	8.3	11,231	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,590	29,308 (0%)	0%	8.3	13,149	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	3,000	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	1,250	1,250	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	4,367	4,367	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	5,900	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	66,500	66,500	-		-	Employee Stock Option (right to purchase)
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	46,300	46,300	-		-	Employee Stock Option (right to purchase)
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	48,500	48,500	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	67,719 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	934	66,785 (0%)	0%	8.3	7,724	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	72,685 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,835	70,850 (0%)	0%	8.3	15,175	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	3,000	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	5,900	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	63,500	63,500	-		-	Employee Stock Option (right to purchase)
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	2,500	39,708 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	2,196	37,512 (0%)	0%	8.3	18,161	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	778	36,734 (0%)	0%	8.3	6,434	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	933	35,801 (0%)	0%	8.3	7,716	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	8,250	8,250	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	3,000	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	2,500	2,500	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	78,000	78,000	-		-	Employee Stock Option (right to purchase)
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	54,100	54,100	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	8,250	34,208 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	3,000	37,208 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	1,836	23,627 (0%)	0%	8.3	15,184	Common Stock
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	2,563	2,564	-		-	Restricted Stock Units
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	5,900	-		-	Restricted Stock Units
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	2,563	25,463 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share.	16 Mar 2023	798	22,900 (0%)	0%	8.3	6,599	Common Stock
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2023	5,900	23,698 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	30 Jan 2023	20,940	76,495 (0%)	0%	5.0	105,538	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 9.55 per share.	30 Jan 2023	14,320	55,555 (0%)	0%	9.6	136,756	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2023	20,939	20,940	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2023	20,939	41,879	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 9.36 per share.	30 Jan 2023	14,550	61,945 (0%)	0%	9.4	136,188	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jan 2023	20,940	0	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	30 Jan 2023	20,939	63,047 (0%)	0%	5.0	105,533	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	30 Jan 2023	20,939	69,875 (0%)	0%	5.0	105,533	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 9.69 per share.	30 Jan 2023	14,111	48,936 (0%)	0%	9.7	136,736	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 10.16 per share.	25 Jan 2023	20,940	42,108 (0%)	0%	10.2	212,750	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jan 2023	20,940	62,818	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jan 2023	20,939	83,758	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	25 Jan 2023	20,939	63,047 (0%)	0%	5.0	105,533	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 10.23 per share.	25 Jan 2023	20,939	42,108 (0%)	0%	10.2	214,206	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	25 Jan 2023	20,939	63,047 (0%)	0%	5.0	105,533	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 9.90 per share.	25 Jan 2023	20,939	42,108 (0%)	0%	9.9	207,296	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	25 Jan 2023	20,940	63,048 (0%)	0%	5.0	105,538	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jan 2023	20,939	104,697	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	649	42,108 (0%)	0%	9.4	6,127	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	2,625	42,757 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	2,625	2,625	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	4,400	1,012,695 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	4,400	0	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	187	106,531 (0%)	0%	9.4	1,765	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	750	106,718 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	27 Dec 2022	20,000	116,752 (0%)	0%	5.1	101,800	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	20,000	0	-		-	Employee Stock Option (right to buy)
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	10,784	105,968 (0%)	0%	9.4	101,801	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	750	0	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	19,347 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	0	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	286	19,061 (0%)	0%	9.4	2,700	Common Stock
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	286	64,719 (0%)	0%	9.4	2,700	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	65,005 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	0	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	286	25,958 (0%)	0%	9.4	2,700	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	26,244 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	0	-		-	Restricted Stock Units
Isabelle Billet	Chief Strategy and BD Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share.	27 Dec 2022	327	25,065 (0%)	0%	9.4	3,087	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	0	-		-	Restricted Stock Units
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2022	1,150	25,392 (0%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2022	26,746	0	-		-	Employee Stock Option (right to buy)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	15 Dec 2022	26,746	1,008,295 (2%)	0%	5.1	136,137	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share.	14 Dec 2022	19,364	49,062 (0%)	0%	5.0	97,595	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Dec 2022	19,364	185,636	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.93 per share.	14 Dec 2022	8,930	40,132 (0%)	0%	10.9	97,605	Common Stock
Joseph Adrian Tyndall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2022	43,171	43,171	-		-	Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 11.88 per share.	16 Nov 2022	10,649	29,698 (0%)	0%	11.9	126,510	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 12.74 per share.	14 Nov 2022	13,000	339,583 (0%)	0%	12.7	165,620	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 12.50 per share.	08 Nov 2022	13,000	352,583 (0%)	0%	12.5	162,500	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 9.70 per share.	10 Aug 2022	8,886	365,583 (0%)	0%	9.7	86,159	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 10.37 per share.	04 Aug 2022	13,046	374,469 (0%)	0%	10.4	135,287	Common Stock
Gregory G. Freitag	Director	Sale of securities on an exchange or to another person at price $ 10.64 per share.	04 Aug 2022	24,000	387,515 (0%)	0%	10.6	255,360	Common Stock
Gregory G. Freitag	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.26 per share.	25 Jul 2022	30,296	411,515 (1%)	0%	9.3	280,541	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jul 2022	83,000	0	-		-	Employee Stock Option (right to purchase)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.38 per share.	25 Jul 2022	83,000	441,811 (1%)	0%	3.4	280,540	Common Stock
William P. Burke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2022	59,395	0	-		-	Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	947	40,347 (0%)	0%	8.4	7,955	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	3,710	38,294 (0%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	22,076	988,409 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	9,081	981,549 (2%)	0%	8.4	76,280	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	405	96,752 (0%)	0%	8.4	3,402	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	1,579	94,157 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	2,571	18,854 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	657	18,197 (0%)	0%	8.4	5,519	Common Stock
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	2,571	64,512 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	657	63,855 (0%)	0%	8.4	5,519	Common Stock
Angelo Scopelianos	Chief R&D Officer	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	657	25,094 (0%)	0%	8.4	5,519	Common Stock
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	2,571	22,751 (0%)	0%		0	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	2,571	24,340 (0%)	0%		0	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	751	24,242 (0%)	0%	8.4	6,308	Common Stock
Eric Sandberg	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 8.40 per share.	18 Jul 2022	1,125	16,081 (0%)	0%	8.4	9,450	Common Stock
Eric Sandberg	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	4,408	17,206 (0%)	0%		0	Common Stock
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	51,800 (0%)	0%		0	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Stock Option (right to purchase)
John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Employee Stock Option (right to purchase)
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Stock Option (right to purchase)
Paul G. Thomas	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	3,036	3,036 (0%)	0%		0	Common Stock
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	35,133 (0%)	0%		0	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Stock Option (right to purchase)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	358,811 (0%)	0%		0	Common Stock
Gregory G. Freitag	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Employee Stock Option (right to purchase)
Mark S. Gold	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Stock Option (right to purchase)
Mark S. Gold	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	305,475 (0%)	0%		0	Common Stock
Mark S. Gold	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Mark S. Gold	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	6,459	6,459	-		-	Restricted Stock Units
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	11,800 (0%)	0%		0	Common Stock
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	3,036	0	-		-	Restricted Stock Units
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	11,811	11,811	-		-	Stock Option (right to purchase)
Bradley Ottinger	General Counsel and CCO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	01 Jun 2022	3,775	14,798 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	15,500	18,573 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2022	15,500	15,500	-		-	Restricted Stock Units
Quentin S. Blackford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Mar 2022	3,036	27,335 (0%)	0%		0	Common Stock
Quentin S. Blackford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Mar 2022	3,036	0	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	11,000	37,353 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	103,079	103,079	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	76,780	76,780	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	11,000	11,000	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	2,769	34,584 (0%)	0%	8.0	22,069	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	25,950	25,950	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	317,185	317,185	-		-	Employee Stock Option (right to purchase)
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	169,694	169,694	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	25,950	966,333 (2%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	6,000	-		-	Restricted Stock Units
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	33,419	33,419	-		-	Employee Stock Option (right to purchase)
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	25,845 (0%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	1,502	24,343 (0%)	0%	8.0	11,971	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	35,829	35,829	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	6,000	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	25,450	25,450	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	23,738	23,738	-		-	Employee Stock Option (right to purchase)
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	94,075 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	1,497	92,578 (0%)	0%	8.0	11,931	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	4,366	11,022 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	30,348	30,348	-		-	Employee Stock Option (right to purchase)
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	32,536	32,536	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	8,500	8,500	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	4,366	8,734	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	3,239	16,283 (0%)	0%	8.0	25,815	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	8,500	19,522 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	63,453 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	34,745	34,745	-		-	Employee Stock Option (right to purchase)
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	37,250	37,250	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	6,000	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	1,512	61,941 (0%)	0%	8.0	12,051	Common Stock
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	42,563	42,563	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	11,000	22,950 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	2,770	20,180 (0%)	0%	8.0	22,077	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	11,000	11,000	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	39,700	39,700	-		-	Employee Stock Option (right to purchase)
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	8,500	24,216 (0%)	0%		0	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	23,354	23,354	-		-	Restricted Stock Units
Isabelle Billet	Chief Strategy and BD Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	21,784	21,784	-		-	Employee Stock Option (right to purchase)
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	8,500	8,500	-		-	Restricted Stock Units
Isabelle Billet	Chief Strategy and BD Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	2,447	21,769 (0%)	0%	8.0	19,503	Common Stock
Eric Sandberg	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	60,576	60,576	-		-	Employee Stock Option (right to purchase)
Eric Sandberg	Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	1,512	12,798 (0%)	0%	8.0	12,051	Common Stock
Eric Sandberg	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	6,000	-		-	Restricted Stock Units
Eric Sandberg	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	62,910	62,910	-		-	Restricted Stock Units
Eric Sandberg	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	6,000	14,310 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	2,563	3,721 (0%)	0%		0	Common Stock
Bradley Ottinger	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	41,948	41,948	-		-	Employee Stock Option (right to purchase)
Bradley Ottinger	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2022	44,973	44,973	-		-	Restricted Stock Units
Bradley Ottinger	General Counsel and CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2022	2,563	5,127	-		-	Restricted Stock Units
Bradley Ottinger	General Counsel and CCO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share.	16 Mar 2022	648	3,073 (0%)	0%	8.0	5,165	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share.	22 Feb 2022	5,000	57,453 (0%)	0%	5.5	27,250	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2022	5,000	0	-		-	Employee Stock Option (right to purchase)
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2022	10,000	0	-		-	Employee Stock Option (right to purchase)
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	22 Feb 2022	10,000	52,453 (0%)	0%	5.1	50,900	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	3,157	27,303 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	950	26,353 (0%)	0%	8.4	7,999	Common Stock
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	13,978	940,383 (2%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	1,181	20,202 (0%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	357	19,845 (0%)	0%	8.4	3,006	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	357	88,075 (0%)	0%	8.4	3,006	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	1,181	88,432 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	400	6,656 (0%)	0%	8.4	3,368	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	1,325	7,056 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	205	42,453 (0%)	0%	8.4	1,726	Common Stock
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	675	42,658 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	400	11,950 (0%)	0%	8.4	3,368	Common Stock
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	1,325	12,350 (0%)	0%		0	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	447	15,716 (0%)	0%	8.4	3,764	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	1,325	16,163 (0%)	0%		0	Common Stock
Eric Sandberg	Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share.	15 Feb 2022	762	8,310 (0%)	0%	8.4	6,416	Common Stock
Eric Sandberg	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	2,531	9,072 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	2,625	24,794 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	2,625	2,625	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	648	24,146 (0%)	0%	9.7	6,312	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	4,400	4,400	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	4,400	927,429 (2%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	1,752	925,677 (2%)	0%	9.7	17,064	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	17,738 (0%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	286	17,452 (0%)	0%	9.7	2,786	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	1,150	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	750	87,436 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	750	750	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	187	87,249 (0%)	0%	9.7	1,821	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	6,017 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	1,150	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	286	5,731 (0%)	0%	9.7	2,786	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	1,150	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	286	41,983 (0%)	0%	9.7	2,786	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	42,269 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	1,150	-		-	Restricted Stock Units
Angelo Scopelianos	Chief R&D Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	11,270 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	286	10,984 (0%)	0%	9.7	2,786	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	1,150	-		-	Restricted Stock Units
Isabelle Billet	Chief Strategy and BD Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share.	27 Dec 2021	326	14,184 (0%)	0%	9.7	3,175	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	1,150	14,510 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	1,900	22,926 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	1,900	0	-		-	Restricted Stock Units
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	20 Dec 2021	757	22,169 (0%)	0%	9.2	6,995	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	3,125	0	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	20 Dec 2021	1,243	923,029 (2%)	0%	9.2	11,485	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	3,125	924,272 (2%)	0%		0	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	20 Dec 2021	95	16,588 (0%)	0%	9.2	878	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	375	-	-		-	Restricted Stock Units
Mark Louis Friedman	VP Regulatory Affairs & Policy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	375	16,683 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	20 Dec 2021	144	86,686 (0%)	0%	9.2	1,331	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	575	0	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	575	86,830 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	375	41,214 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2021	375	0	-		-	Restricted Stock Units
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	20 Dec 2021	95	41,119 (0%)	0%	9.2	878	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share.	15 Dec 2021	10,000	90,426 (0%)	0%	3.7	36,700	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2021	10,000	0	-		-	Employee Stock Option (right to buy)
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.80 per share.	15 Dec 2021	4,171	86,255 (0%)	0%	8.8	36,705	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.95 per share.	24 Nov 2021	52,375	921,147 (2%)	0%	8.9	468,756	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Nov 2021	52,375	157,125	-		-	Employee Stock Option (right to purchase)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	12 Aug 2021	8,254	822,272 (2%)	0%	5.1	42,013	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Aug 2021	46,500	0	-		-	Employee Stock Option (right to buy)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Aug 2021	8,254	26,746	-		-	Employee Stock Option (right to buy)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share.	12 Aug 2021	46,500	868,772 (2%)	0%	3.7	170,655	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.41 per share.	06 Aug 2021	22,902	816,101 (2%)	0%	18.4	421,626	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Aug 2021	75,000	35,000	-		-	Employee Stock Option (right to purchase)
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.16 per share.	06 Aug 2021	2,083	814,018 (2%)	0%	19.2	39,910	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	06 Aug 2021	75,000	855,018 (2%)	0%	5.1	381,750	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.18 per share.	06 Aug 2021	1,259	839,003 (2%)	0%	19.2	24,148	Common Stock
Karen Zaderej	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.40 per share.	06 Aug 2021	14,756	840,262 (2%)	0%	18.4	271,510	Common Stock
Michael Patrick Donovan	VP Operations	Sale of securities on an exchange or to another person at price $ 20.04 per share.	21 Jul 2021	1,935	40,839 (0%)	0%	20.0	38,777	Common Stock
John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	27,638	27,638	-		-	Stock Options (right to buy)
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	3,710	21,944 (0%)	0%		0	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	918	21,026 (0%)	0%	19.2	17,626	Common Stock
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	22,077	788,830 (1%)	0%		0	Common Stock
Karen Zaderej	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	8,812	780,018 (1%)	0%	19.2	169,190	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	637	16,308 (0%)	0%	19.2	12,230	Common Stock
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	2,572	16,945 (0%)	0%		0	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	392	80,426 (0%)	0%	19.2	7,526	Common Stock
Erick Wayne DeVinney	VP Peripheral Nerve Science	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	1,580	80,818 (0%)	0%		0	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	637	4,867 (0%)	0%	19.2	12,230	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	2,572	5,504 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	2,572	43,411 (0%)	0%		0	Common Stock
Michael Patrick Donovan	VP Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	637	42,774 (0%)	0%	19.2	12,230	Common Stock
Angelo Scopelianos	Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	2,572	10,757 (0%)	0%		0	Common Stock
Angelo Scopelianos	Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	637	10,120 (0%)	0%	19.2	12,230	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	728	13,360 (0%)	0%	19.2	13,978	Common Stock
Isabelle Billet	Chief Strategy and BD Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	2,572	14,088 (0%)	0%		0	Common Stock
Eric Sandberg	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2021	4,408	7,631 (0%)	0%		0	Common Stock
Eric Sandberg	Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share.	19 Jul 2021	1,090	6,541 (0%)	0%	19.2	20,928	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.17 per share.	17 Jun 2021	9,250	364,556 (0%)	0%	19.2	177,323	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jun 2021	9,250	0	-		-	Employee Stock Option (right to purchase)
Gregory G. Freitag	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.92 per share.	17 Jun 2021	8,781	355,775 (0%)	0%	20.9	183,699	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Jun 2021	24,000	0	-		-	Employee Stock Option (right to buy)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share.	04 Jun 2021	24,000	355,306 (0%)	0%	3.7	88,080	Common Stock
Maria D. Martinez	Chief Human Resources Officer	Sale of securities on an exchange or to another person at price $ 18.86 per share.	04 Jun 2021	2,652	2,932 (0%)	0%	18.9	50,017	Common Stock
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to purchase)
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	0	-		-	Restricted Stock Units
Guido J. Neels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	48,764 (0%)	0%		0	Common Stock
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to buy)
Paul G. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to purchase)
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	32,097 (0%)	0%		0	Common Stock
Amy A. Wendell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	0	-		-	Restricted Stock Units
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Gregory G. Freitag	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to purchase)
Gregory G. Freitag	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Mark S. Gold	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	0	-		-	Restricted Stock Units
Mark S. Gold	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	302,439 (0%)	0%		0	Common Stock
Mark S. Gold	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Mark S. Gold	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to buy)
Quentin S. Blackford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Quentin S. Blackford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	24,299 (0%)	0%		0	Common Stock
Quentin S. Blackford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	0	-		-	Restricted Stock Units
Quentin S. Blackford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to purchase)
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	3,036	3,036	-		-	Restricted Stock Units
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	8,764 (0%)	0%		0	Common Stock
Alan M. Levine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	6,173	0	-		-	Restricted Stock Units
Alan M. Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2021	6,030	6,030	-		-	Stock Option (right to buy)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	26 May 2021	9,000	260,306 (0%)	0%	5.1	45,810	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.95 per share.	26 May 2021	50,000	331,306 (0%)	0%	9.0	447,500	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share.	26 May 2021	15,000	281,306 (0%)	0%	5.5	81,750	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share.	26 May 2021	6,000	266,306 (0%)	0%	5.5	32,700	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share.	26 May 2021	22,954	251,306 (0%)	0%	3.7	84,241	Common Stock
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2021	50,000	0	-		-	Employee Stock Option (right to purchase)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2021	15,000	0	-		-	Stock Option (right to purchase)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2021	6,000	0	-		-	Employee Stock Option (right to purchase)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2021	9,000	0	-		-	Employee Stock Option (right to purchase)
Gregory G. Freitag	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2021	22,954	0	-		-	Employee Stock Option (right to purchase)
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 May 2021	15,000	0	-		-	Stock Option (right to purchase)
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 May 2021	25,000	0	-		-	Stock Option (right to buy)
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	19 May 2021	15,000	42,591 (0%)	0%	5.1	76,350	Common Stock
Guido J. Neels	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share.	19 May 2021	25,000	27,591 (0%)	0%	3.8	95,000	Common Stock
Erick Wayne DeVinney	VP of Clin. & Trans. Sciences	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2021	10,000	0	-		-	Employee Stock Option (right to buy)
Erick Wayne DeVinney	VP of Clin. & Trans. Sciences	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share.	28 Apr 2021	10,000	78,082 (0%)	0%	2.9	28,600	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Apr 2021	100,000	110,000	-		-	Employee Stock Option (right to purchase)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share.	16 Apr 2021	100,000	765,912 (1%)	0%	5.1	509,000	Common Stock
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Mar 2021	19,000	0	-		-	Employee Stock Option (right to buy)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Mar 2021	15,500	0	-		-	Employee Stock Option (right to buy)
Karen Zaderej	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share.	25 Mar 2021	34,500	665,912 (1%)	0%	3.7	126,615	Common Stock
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	61,000	61,000	-		-	Employee Stock Option (right to purchase)
Peter J. Mariani	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	30,500	30,500	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	50,000	50,000	-		-	Restricted Stock Units
Karen Zaderej	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	76,600	76,600	-		-	Employee Stock Option (right to purchase)
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	23,500	23,500	-		-	Employee Stock Option (right to purchase)
Mark Louis Friedman	VP Regulatory Affairs & Policy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	11,800	11,800	-		-	Restricted Stock Units
Erick Wayne DeVinney	VP, Clinical&Translational Sc	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	23,500	23,500	-		-	Employee Stock Option (right to purchase)
Erick Wayne DeVinney	VP, Clinical&Translational Sc	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	11,800	11,800	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	13,100	24,900	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	11,800	11,800	-		-	Restricted Stock Units
Maria D. Martinez	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	23,500	23,500	-		-	Employee Stock Option (right to purchase)
Michael Patrick Donovan	VP Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2021	11,800	11,800	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

233.33% Gain from 52W Low

Insider Trading disclosures for Axogen Inc.

The latest disclosure was made by Michael J. Dale in Axogen Inc. where a trade of 176,300 Restricted Stock Units done was reported to US exchanges on March 25, 2025.

Screeners based on Insider Trading and SAST parameters